Literature DB >> 3498580

Abnormalities in the immune system of children with beta-thalassaemia major.

J Dwyer1, C Wood, J McNamara, A Williams, W Andiman, L Rink, T O'Connor, H Pearson.   

Abstract

We have studied both the humoral and cell mediated immune systems of 23 children with beta-thalassaemia major. In children who had not been splenectomized, a 3-fold expansion in the number of circulating B cells and a modest polyclonal gammopathy was present. Of these patients 70% had decreased numbers of circulating T4 cells; 83% were unresponsive to skin testing with Candida albicans, and the majority had decreased lymphocyte proliferative responses in vitro. In children who had been splenectomized, there was a 10-fold increase in the number of circulating B lymphocytes and a 2-fold increase in the number of T4 and T8 cells present in peripheral blood. Additionally, these patients as a group were more responsive to both skin testing and lymphocyte stimulation in vitro with Candida albicans. Seven patients had an inverted T4/T8 ratio. One child has positive serology to HIV by ELISA and Western Blot techniques with a normal T4/T8 ratio. Thus, while children with thalassaemia are at risk for exposure to HIV, the immunological abnormalities associated with the disease and/or its treatment necessitates cautious interpretation of any AIDS-related immunological changes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3498580      PMCID: PMC1542746     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Immunologic abnormalities in patients receiving multiple blood transfusions.

Authors:  P Gascón; N C Zoumbos; N S Young
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

2.  The regulation of T cell responses by spontaneously active suppressor cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

3.  Raised IgE levels in beta-thalassaemia: correlation with splenectomy and hepatitis B virus infection.

Authors:  A Vierucci; M de Martino; M E Rossi; C Vullo; L Borgatti; W T London; B S Blumberg
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

4.  Impaired T-cell mitogen responses in some patients with thalassemia intermedia.

Authors:  C G Munn; A L Markenson; A Kapadia; M de Sousa
Journal:  Thymus       Date:  1981-08

5.  Lymphoid cell sets and serum immunoglobulins in patients with thalassaemia intermedia: relationship to serum iron and splenectomy.

Authors:  A Kapadia; M de Sousa; A L Markenson; D R Miller; R A Good; S Gupta
Journal:  Br J Haematol       Date:  1980-07       Impact factor: 6.998

6.  Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation.

Authors:  H M Lederman; A Cohen; J W Lee; M H Freedman; E W Gelfand
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

7.  Elevated IgG and decreased complement component C3 and factor B in B-thalassaemia major.

Authors:  D Sinniah; M Yadav
Journal:  Acta Paediatr Scand       Date:  1981-07

8.  Serum immunoglobulins in homozygous beta-thalassemia.

Authors:  P A Tovo; R Miniero; C Barbera; L Sacchetti; M Saitta
Journal:  Acta Haematol       Date:  1981       Impact factor: 2.195

9.  Human blood lymphocyte subpopulations from birth to eight years.

Authors:  R P Falcão
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

10.  Immunoglobulin levels, opsonic activity and phagocytic power in Egyptian thalassemic children.

Authors:  A S Khalifa; S A Fattah; Z Maged; F Sabry; H A Mohamed
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

View more
  14 in total

Review 1.  Immune cell functions in iron overload.

Authors:  M de Sousa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

Review 2.  Evaluation of myocardial iron overload using magnetic resonance imaging.

Authors:  Sophie Mavrogeni
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

3.  Community-acquired meningitis and sepsis caused by Chryseobacterium meningosepticum in a patient diagnosed with thalassemia major.

Authors:  Nisel Ozkalay; Murat Anil; Neval Agus; Mehmet Helvaci; Seral Sirti
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Serum immunoglobulins, IgG subclasses, isohemagglutinins and complement-3 levels in patients with thalassemia major.

Authors:  C Vergin; N Kutukculer; N Cetingul; G Nisli; S Caglayan; S Oztop
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

5.  Leukocytes apoptosis and adipocytokines in children with beta thalassemia major.

Authors:  Khalid I Elsayh; Wafaa S Mohammed; Asmaa M Zahran; Khaled Saad
Journal:  Clin Exp Med       Date:  2015-06-09       Impact factor: 3.984

6.  Phenotypical and functional abnormalities of circulating neutrophils in patients with β-thalassemia.

Authors:  Brigitta Buttari; Elisabetta Profumo; Patrizia Caprari; Sara Massimi; Francesco Sorrentino; Laura Maffei; Marco Gabbianelli; Rachele Riganò
Journal:  Ann Hematol       Date:  2020-08-15       Impact factor: 3.673

7.  Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease.

Authors:  Weili Bao; Hui Zhong; Deepa Manwani; Ljiljana Vasovic; Joan Uehlinger; Margaret T Lee; Sujit Sheth; Patricia Shi; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2013-06-20       Impact factor: 10.047

8.  The IgM and IgG antibody responses in iron-deficient and iron-loaded mice.

Authors:  F O Omara; B R Blakley
Journal:  Biol Trace Elem Res       Date:  1994 Oct-Nov       Impact factor: 3.738

9.  Serum immunoglobulin levels in splenectomized and non- splenectomized patients with major Beta-thalassemia.

Authors:  Mojgan Kiani-Amin; Mohammadmehdi Daneshi; Parviz Ayazi; Shima Mohammadian; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

10.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.